As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times. Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.
COVID-19 and impact on peer review
Call for papers: The impact of genomics on precision public health
Submit to our upcoming special issue 'The impact of genomics on precision public health', guest-edited by Muin Khoury and Kathryn Holt.
Expression of endogenous retroelements
Pierre Thibault, Claude Perreault and colleagues present a comprehensive transcriptomic characterization of endogenous retroelement expression in human tissues and cell types.
Lymphoma clinical trial outcome
Wei-Li Zhao and colleagues report clinical trial results of an alternating treatment regimen in lymphoma.
Neuropsychiatric genetics and genomics
Elliott Rees and Michael Owen discuss recent advances in psychiatric genomics and their translational impact.
Reviews, Research Highlights and Commentaries
Read authoritative Reviews, Opinions and other content commissioned by the Genome Medicine Editors from leading researchers:
Commentaries (including Editorials, Comments, Opinions, Q&As and Meeting reports)
Articles
-
-
Polygenic risk scores: from research tools to clinical instruments
-
CEOP/IVE/GDP alternating regimen compared with CEOP as the first-line therapy for newly diagnosed patients with peripheral T cell lymphoma: results from a phase 2, multicenter, randomized, controlled clinical trial
-
Translating insights from neuropsychiatric genetics and genomics for precision psychiatry
-
EM-mosaic detects mosaic point mutations that contribute to congenital heart disease
-
Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden
-
A practical guide to single-cell RNA-sequencing for biomedical research and clinical applications
-
Alterations in fecal microbiota composition by probiotic supplementation in healthy adults: a systematic review of randomized controlled trials
-
The virome: a missing component of biological interaction networks in health and disease
-
Impact of the gut microbiota on inflammation, obesity, and metabolic disease
Focus: the Gut Microbiome
Read the latest papers on gut microbiota across BMC flagship journals.
Celiac disease: a comprehensive current review
Giacomo Caio et al.
Published in BMC Medicine 23 July 2019
Distinct impact of antibiotics on the gut microbiome and resistome: a longitudinal multicenter cohort study
Matthias Willmann et al.
Published in BMC Biology 18 September 2019
Interactions between the gut microbiome and host gene regulation in cystic fibrosis
Gargi Dayama et al.
Published in Genome Medicine 28 January 2020
Population dynamics of the human gut microbiome: change is the only constant
Sambhawa Priya and Ran Blekhman
Published in Genome Biology 31 July 2019
Aims and scope
Genome Medicine publishes important advances of broad interest in the application of genetics, genomics and multi-omics to understand, diagnose and treat disease. The Journal aims to bridge the basic science and clinical research communities in areas that include, but are not limited to: cancer genomics, immuno-oncology, immunogenomics, infectious disease, microbiome, neurogenomics, systems medicine, clinical genomics, gene therapies, precision medicine, and clinical trials. The Journal content includes original research, method, software, database and guideline articles as well as reviews, opinions and commentaries.
Article collections
Special issue
Clinical interpretation of genome variation
Guest editors: Heidi Rehm and Douglas Fowler
Collection
A decade of Genome Medicine
Special issue
Tumor immune microenvironment and immunotherapy
Guest editors: Zlatko Trajanoski and Noel de Miranda
Special issue
From genome integrity to cancer
Guest editor: Serena Nik-Zainal
Advertisement
- Editorial Board
- Editorial Team
- Sign up for article alerts and news from this journal
- Contact us
-
Announcements
In response to the current outbreak of Coronavirus, responsible for COVID-19, Genome Medicine editors will treat relevant submissions with high priority.
Follow
2018 Journal Metrics
-
Citation Impact
10.886 - 2-year Impact Factor
9.368 - 5-year Impact Factor
1.833 - Source Normalized Impact per Paper (SNIP)
5.084 - SCImago Journal Rank (SJR)
Advertisement
